Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Clinical Journal of the American Society of Nephrology : CJASN|October 4, 2017
Metabolomic Alterations Associated with Cause of CKDMorgan E Grams, Adrienne Tin, Casey M Rebholz, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 TrialVicente E Torres, Eiji Higashihara, Olivier Devuyst, et al.
The New England Journal of Medicine|November 6, 2012
Tolvaptan in patients with autosomal dominant polycystic kidney diseaseVicente E Torres, Arlene B Chapman, Olivier Devuyst, et al.
BMC Nephrology|May 27, 2017
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regressionMyrte K Neijenhuis, Wietske Kievit, Ronald D Perrone, et al.
Kidney International Reports|November 17, 2017
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney DiseaseRonald D Perrone, Mohamad-Samer Mouksassi, Klaus Romero, et al.
Kidney360|July 28, 2021
Association of Baseline Urinary Metabolic Biomarkers with ADPKD Severity in TAME-PKD Clinical Trial ParticipantsKenneth R Hallows, Andrew D Althouse, Hui Li, et al.
Kidney International Reports|November 17, 2017
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney DiseaseRonald D Perrone, Mohamad-Samer Mouksassi, Klaus Romero, et al.
Environmental Toxicology and Pharmacology|November 28, 2024
Harnessing H<sub>2</sub>O<sub>2</sub>-induced susceptibility in Galleria mellonella larvae: A robust model for exploring oxidative stress and biomarkersL M M Mattos, R N Silva, L G Santos, et al.
The New England Journal of Medicine|November 7, 2017
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney DiseaseVicente E Torres, Arlene B Chapman, Olivier Devuyst, et al.
Gastroenterology|February 1, 1995
Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell linesS A Grubman, S L Fang, A E Mulberg, et al.
Pageof 16